The aim of this study was to describe the population pharmacokinetics of ticarcillin during extended daily diafiltration (EDDf) in critically ill patients with acute kidney injury. Blood samples were collected from critically ill patients prescribed ticarcillin during one to two dosing intervals during which EDDf was performed. Plasma samples were measured using a validated ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method. Concentration-time data were analysed using a population pharmacokinetics approach with Pmetrics®. A total of 53 blood samples were collected from six critically ill patients (three male). The mean ± standard deviation patient age, weight and body mass index (BMI) was 43 ± 22 year...
Determining appropriate antibiotic dosing for critically ill patients receiving renal replacement th...
none5noContinuous renal replacement therapy (CRRT), particularly continuous venovenous haemofiltrati...
This study describes the population pharmacokinetics of fosfomycin in critically ill patients. In th...
Piperacillin is a β-lactam penicillin antibiotic commonly used for the empirical therapy of sepsis a...
OBJECTIVES: The study aimed to characterize the pharmacokinetics (PK) of four β-lactams (piperacilli...
Objectives: The objective of this study was to investigate the population pharmacokinetics and pharm...
Background: Population pharmacokinetic (popPK) models for antibiotics are used to improve dosing st...
Optimal antibiotic dosing is key to maximising patient survival, and minimising the emergence of bac...
INTRODUCTION: Continuous renal replacement therapy (CRRT) may alter antibiotic pharmacokinetics and ...
Background: Sustained low-efficiency dialysis (SLED), is increasingly being used in intensive care u...
The objective of this study was to describe amikacin pharmacokinetics (PK) in critically ill patient...
The severity of diseases, the complexity of treatment, and the use of medical devices in the intensi...
BACKGROUND: Optimal antibiotic dosing is key to maximising patient survival, and minimising the emer...
The objective of the present prospective pharmacokinetic study was to describe the variability of pl...
International audienceWe sought to describe the population pharmacokinetics of tigecycline in critic...
Determining appropriate antibiotic dosing for critically ill patients receiving renal replacement th...
none5noContinuous renal replacement therapy (CRRT), particularly continuous venovenous haemofiltrati...
This study describes the population pharmacokinetics of fosfomycin in critically ill patients. In th...
Piperacillin is a β-lactam penicillin antibiotic commonly used for the empirical therapy of sepsis a...
OBJECTIVES: The study aimed to characterize the pharmacokinetics (PK) of four β-lactams (piperacilli...
Objectives: The objective of this study was to investigate the population pharmacokinetics and pharm...
Background: Population pharmacokinetic (popPK) models for antibiotics are used to improve dosing st...
Optimal antibiotic dosing is key to maximising patient survival, and minimising the emergence of bac...
INTRODUCTION: Continuous renal replacement therapy (CRRT) may alter antibiotic pharmacokinetics and ...
Background: Sustained low-efficiency dialysis (SLED), is increasingly being used in intensive care u...
The objective of this study was to describe amikacin pharmacokinetics (PK) in critically ill patient...
The severity of diseases, the complexity of treatment, and the use of medical devices in the intensi...
BACKGROUND: Optimal antibiotic dosing is key to maximising patient survival, and minimising the emer...
The objective of the present prospective pharmacokinetic study was to describe the variability of pl...
International audienceWe sought to describe the population pharmacokinetics of tigecycline in critic...
Determining appropriate antibiotic dosing for critically ill patients receiving renal replacement th...
none5noContinuous renal replacement therapy (CRRT), particularly continuous venovenous haemofiltrati...
This study describes the population pharmacokinetics of fosfomycin in critically ill patients. In th...